| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.18B | +31.4% |
| Cost of Revenue | $988.2M | -44.4% |
| Gross Profit | $196.3M | +122.4% |
| R&D Expense | $221.3M | -20.2% |
| SG&A Expense | $101.0M | -31.5% |
| Operating Income | -$301.7M | +82.3% |
| Pre-tax Income | -$391.1M | +77.1% |
| Income Tax | $13.4M | -86.1% |
| Net Income | -$405.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $455.1M | +65.7% |
| Short-term Investments | $38.1M | -87.8% |
| Accounts Receivable | $267.4M | +66.7% |
| Inventory | $552.6M | -14.4% |
| Current Assets | $1.74B | -14.5% |
| Total Assets | $2.18B | -17.0% |
| Current Liabilities | $803.5M | -22.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $104.3M | +133.3% |
| Capital Expenditures | $23.5M | -78.3% |
| Investing Cash Flow | $379.9M | -8.7% |
| Financing Cash Flow | -$348.9M | -1633.3% |
| Free Cash Flow | $80.8M | +119.2% |
| +67.7% |
| EPS (Basic) | -$6.88 | +78.3% |
| EPS (Diluted) | -$6.88 | +78.3% |
| Stockholders' Equity |
| $427.5M |
| -35.1% |